The influence of the COVID-19 pandemic on the prescription of multiple sclerosis medication in Germany

BACKGROUND: Real-word evidence from diverse data sources is increasingly important in terms of generating rapid insights to effectively manage patient populations, especially during major public health disruptions such as the ongoing COVID-19 pandemic. Patients with chronic and inflammatory diseases...

Descripción completa

Detalles Bibliográficos
Autores principales: Orschiedt, Jonathan, Jacyshyn-Owen, Elizabeth, Kahn, Maria, Jansen, Sven, Joschko, Natalie, Eberl, Markus, Schneeweiss, Sebastian, Friedrich, Benjamin, Ziemssen, Tjalf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Masson SAS. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756211/
https://www.ncbi.nlm.nih.gov/pubmed/36527843
http://dx.doi.org/10.1016/j.biopha.2022.114129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756211/
https://www.ncbi.nlm.nih.gov/pubmed/36527843
http://dx.doi.org/10.1016/j.biopha.2022.114129

Ejemplares similares